» Articles » PMID: 28039497

Synergistic Effects of Fenbendazole and Metronidazole Against Giardia Muris in Swiss Mice Naturally Infected

Overview
Journal Parasitol Res
Specialty Parasitology
Date 2017 Jan 1
PMID 28039497
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In this study were proposed different protocols for the treatment of mice naturally infected with Giardia muris. Male Swiss mice were divided into seven groups, with five animals each, in a blind, controlled, randomized by drawing lots and once-repeated experiment. Parasite detection and cure control were performed using the Faust method and search by trophozoites in the intestinal mucosa. Clinical parameters (weight, water and feed consumption, elimination of excreta, aspect of the fur and feces) were also evaluated. All animals were treated with metronidazole (M), fenbendazole (F), and probiotics (P), administered intragastrically, during 7 days. M1, FM1, and F1 groups were treated 1×/day; M3, FM3, and PM3 groups 3×/day; and ST (control group) received only water. After the 5th and 7th days of treatment, the animals in FM1/FM3 and PM3/M3 groups presented, respectively, negative results and remained negative in the following 10 days. Animals in F1 group consumed less water (p = 0.00010) compared with FM1/FM3/PM3. The animals in M1 group compared with FM3/M3, F1 compared with M3, and ST compared with FM1/FM3/M3/PM3 consumed a larger amount of feed (p = 0.00001). The animals in F1 group compared with FM3/M1/M3/PM3, FM1 compared with FM3, and ST compared with FM3/M1/M3/PM3 eliminated lower volume of excreta (p = 0.00001). The results show that the association between F and M potentiates the effects, indicating a synergistic action of these two drugs, and FM1 is the best protocol due to early negativity in the animals, lower concentrations of the drugs, lower risk of toxicity and stress, and less alterations in clinical parameters.

Citing Articles

Identification and management of infections caused by sp., sp. and sp. in captive Brazilian porcupines ().

More G, Ruegg-van den Broek P, Glardon O, Gliga D, Frey C, Basso W Int J Parasitol Parasites Wildl. 2024; 25:100976.

PMID: 39351490 PMC: 11440209. DOI: 10.1016/j.ijppaw.2024.100976.


Evaluating the Effect of Lactobacillus casei FEGY 9973 and Curcumin on Experimental Giardiasis.

Shady O, Shalash I, Elshaghabee F, Negm M, Yousef G, Rizk E Acta Parasitol. 2023; 69(1):302-308.

PMID: 38060086 PMC: 11001656. DOI: 10.1007/s11686-023-00744-4.


Evaluation of Therapeutic Approaches for the Treatment of in Mice.

Voros G, Blair R, Andrews D, Dobek G J Am Assoc Lab Anim Sci. 2021; 60(2):146-151.

PMID: 33419496 PMC: 7974821. DOI: 10.30802/AALAS-JAALAS-20-000067.


Encapsulation of Low Metronidazole Dose in Poly (D,L-lactide-co-glycolide) (PLGA) Nanoparticles Improves Treatment.

Madbouly N, Nashee H, Elgendy A, Rabee I, Amir A Infect Chemother. 2020; 52(4):550-561.

PMID: 33377322 PMC: 7779986. DOI: 10.3947/ic.2020.52.4.550.

References
1.
Baker D . Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev. 1998; 11(2):231-66. PMC: 106832. DOI: 10.1128/CMR.11.2.231. View

2.
Brener Z . Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo. 1962; 4:389-96. View

3.
Besirbellioglu B, Ulcay A, Can M, Erdem H, Tanyuksel M, Avci I . Saccharomyces boulardii and infection due to Giardia lamblia. Scand J Infect Dis. 2006; 38(6-7):479-81. DOI: 10.1080/00365540600561769. View

4.
Shukla G, Devi P, Sehgal R . Effect of Lactobacillus casei as a probiotic on modulation of giardiasis. Dig Dis Sci. 2008; 53(10):2671-9. DOI: 10.1007/s10620-007-0197-3. View

5.
Beyhan Y, Hokelek M . [Giardia muris infection in laboratory rats (Rattus norvegicus) and treatment with metronidazole]. Turkiye Parazitol Derg. 2014; 38(3):181-4. DOI: 10.5152/tpd.2014.3469. View